A study to see if injecting a numbing medicine into the ear helps reduce ringing sound in the ear compared to injection of plain fluid.

Effect of intratympanic lidocaine injection on patients suffering from cochlear synaptic tinnitus comparing with placebo (intratympanic ringer lactate injection) - randomized blinded controlled - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110559

Enrollment

Registered

2026-05-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H932- Other abnormal auditory perceptions

Interventions

Intervention1: Intratympanic lidocaine injection: Lidocaine injection is local anaesthetic which block sodium channels on neuron, will be given intratympanic Control Intervention1: Intratympanic ringe

Eligibility

Inclusion criteria

Inclusion criteria: Age of Patient between 18 and 60 years Unilateral or Bilateral Tinnitus Intact tympanic membrane

Exclusion criteria

Exclusion criteria: Concomitant symptoms (like any Psychiatric illness) Pregnancy or plan for having children Retrocochlear hearing defect Blast injury Status post psychiatrist therapy Known to allergy to lidocaine Medicative tinnitus therapy at least 1 week prior to enrolment Tinnitus due to known intracranial disease Drug induced tinnitus

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness of intratympanic injection of lidocaine in reducing tinnitus severity, measured by Tinnitus Handicap Index Score.Timepoint: Follow up at 1,3 and 6 month	—

Secondary

Measure	Time frame
To see severity & observe Post procedural complications.Timepoint: For 2 hour	—

Countries

India

Contacts

Public ContactDr Jagdeep Thakur

Government medical College

anujagdeep@gmail.com9418477400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026